Supplemental material
Hematology
Volume 26, 2021 - Issue 1
Articles
Effectiveness and safety of romiplostim among patients with newly diagnosed, persistent and chronic ITP in routine clinical practice in central and Eastern Europe: an analysis of the PLATON study
Barbara Skopeca Department of Hematology, University Medical Center Ljubljana, Ljubljana, Slovenia;b Medical Faculty, University of Ljubljana, Ljubljana, SloveniaCorrespondence[email protected]
https://orcid.org/0000-0001-8836-0091View further author information
https://orcid.org/0000-0001-8836-0091View further author information, , Nikolai Tzvetkovd Clinic of Hematology, University Multiprofile Hospital for Active Treatment “Dr. Georgi Stranski” EAD, Pleven, Bulgariahttps://orcid.org/0000-0002-8145-6135View further author information
https://orcid.org/0000-0002-8145-6135View further author information, , Katja Björklöff Medical Affairs, Amgen (Europe North East), Rotkreuz, Switzerlandhttps://orcid.org/0000-0002-7678-5938View further author information
https://orcid.org/0000-0002-7678-5938View further author information, Jane Hippenmeyerg Medical Affairs, Amgen (Europe) GmbH, Rotkreuz, Switzerlandhttps://orcid.org/0000-0002-5480-8916View further author information
https://orcid.org/0000-0002-5480-8916View further author information & Georgi Mihaylovh Clinic of Hematology, Specialized Hospital for Active Treatment of Hematology Diseases AD, Sofia, Bulgariahttps://orcid.org/0000-0002-8435-2825View further author information
https://orcid.org/0000-0002-8435-2825View further author information show all